Alpha DNA Investment Management LLC - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 200 filers reported holding ANI PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Alpha DNA Investment Management LLC ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$558,944
-24.3%
9,627
-29.8%
0.23%
-6.9%
Q2 2023$738,54713,7200.25%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 239,101$8,380,0002.93%
Mesirow Financial Investment Management, Inc. 8,974$315,0000.80%
Parkman Healthcare Partners LLC 55,346$1,940,0000.42%
1492 Capital Management LLC 18,178$637,0000.32%
INVESTMENT COUNSELORS OF MARYLAND LLC 383,696$13,449,0000.31%
PERKINS CAPITAL MANAGEMENT INC 14,076$493,0000.28%
HUSSMAN STRATEGIC ADVISORS, INC. 30,400$1,066,0000.22%
Defender Capital, LLC. 19,000$665,0000.22%
Ranger Investment Management 104,941$3,678,0000.19%
THOMPSON SIEGEL & WALMSLEY LLC 380,474$13,336,0000.18%
View complete list of ANI PHARMACEUTICALS INC shareholders